Drug Search Results

Sorivudine

Alternative Names: sorivudine
Latest Update: 2024-03-19
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Nucleoside Analogue,DNA Polymerase Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bristol-Myers Squibb
Company Location: NEW YORK NY 10016
Company CEO: Giovanni Caforio
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sorivudine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: HIV Infections|Chickenpox

Phase 2: Neuralgia, Postherpetic|Herpes Zoster

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
Shingles	P2	Unknown status	Neuralgia, Postherpetic\|Herpes Zoster	2009-06-01
255A	P3	Completed	HIV Infections\|Chickenpox	None

Recent News Events

Date	Type	Title
03/19/2024	PubMed	Fluoropyrimidine Toxicity: the Hidden Secrets of DPYD.
01/01/2021	PubMed	Identification of potential antivirals against SARS-CoV-2 using virtual screening method.
08/01/2020	PubMed	Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
01/29/2019	News Article	Certara Launches Version 18 of its Physiologically-based Pharmacokinetic (PBPK) Simcyp Simulator

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions